Dalan Animal Health Closes $3M Seed Round to Advance Commercialization of Shrimp Vaccine

Dalan Animal Health, Inc., the pioneering bioscience company that developed the world's first vaccine for invertebrates, today announced the successful closure of a $3 million SAFE (Simple Agreement for Future Equity) funding round. The round included Good Growth Capital together with Meach Cove Capital and other global investors, marking increased international recognition of Dalan's breakthrough Innate Immunity Platform technology.
The new funding will advance the commercialization of Dalan's first-in-class shrimp vaccine, addressing one of the most...
To Read Full Story Login Below.